Materials and methods

Poly (L-
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Electrospinning
PLLA solution was prepared as following: 1 g PLLA was added into 8g DCM, the mixture was stirred severely for 20 minutes, then 4g DMF was added into the mixture to obtain the control electrospinning solution. The electrospinning processes were performed as described previously. 1 Briefly, the following parameters for electrospinning were applied: voltage, 12 kV; solution feed rate, 0.2 ml/min; distance between the needle and the collector, 12 cm; syringe needle diameter, 0.9 mm. All electrospun fibrous scaffolds were dried with vacuum at room temperature for 2 days before using.
PDA coating and CD40mAb grafting onto the electrospun fibers
All solutions used were filtrated for sterilization. PLLA electrospun fibrous scaffolds 4 (PLLA) were immersed in 75% ethanol at room temperature for 5h. The PLLA electrospun fibrous scaffolds were precoated with PDA through incubating with PDA tris-buffer solution (10 mM Tris, pH 8.5) at room temperature for 24 hand rinsed with Phosphate Buffered Saline (PBS, pH 7.4). Then the PDA-coated PLLA electrospun fibrous scaffolds (PLLA-PDA) were immersed into CD40mAb solution (12 μg/ml, PLLA-PDA-CD40mAb) and IgG (12μg/ml, PLLA-PDA-IgG) at 4°C for 24h. The antibody-binding electrospun fibrous scaffolds were rinsed 5 times with PBS for future use.
Characterizations of electrospun microfibers
The morphology of the fibrous scaffolds was observed by scanning electron microscopy (SEM, FEI Quanta 200, Netherlands) with an acceleration voltage of 10 kV. The surface of the fibers was sputter-coated with platinum before SEM observation. A contact angle analyzer (DSA25S, Data Physics Corporation) was applied to measure the static water contact angles (WCA) of the fibrous scaffolds. Xray photoelectron spectroscopy (XPS, XSAM800, Britain) was used to determine the chemical compositions of the fibrous scaffolds surface.
The dry fibrous scaffolds were punched into dumbbell shaped specimens (15.0×3.0×0.13 mm 3 ) before testing. The uniaxial tensile test was administrated by a mechanical testing machine (Hengyi, China).
Binding assay of CD40mAb
PLLA-PDA electrospun fibrous scaffolds (2×3cm 2 ) were immersed in a 1 ml of CD40mAb solution (12 μg/ml) at predetermined time intervals. 20 μl of the released buffer was collected for analysis, and 20μl of fresh PBS was added back for 5 continuing incubation. Subsequently, electrospun fibrous scaffolds were washed with 100 μl PBS to remove unbounded CD40mAb. The amount of unbounded CD40mAb in the washing buffer was determined by BCA Protein Assay Kit (Beyotime, China) according to manufacturer's instructions.
In vitro CD40mAb release
To evaluate the released profile of CD40mAb, the PLLA-PDA-CD40mAb electrospun fibrous scaffolds were first punched into small squares (2×3 cm 2 ), which were then immersed in 500 μl of PBS (pH 7.4) and incubated at 4°C. At predetermined time intervals, 100 μl of the released buffer was collected for analysis, and 100 μl of fresh PBS was added back for continuous incubation. The released CD40mAb in the PBS was determined by BCA Protein Assay Kit (Beyotime, China) according to manufacturer's instructions.
Detection of CD40mAb grafting onto the electrospun fibrous scaffolds
The grafting of CD40mAb on the PLLA-PDA electrospun fibrous scaffolds was further analyzed by immunofluorescence staining. The electrospun fibrous scaffolds (2×3 cm 2 ) were immersed in CD40mAb-FITC (12 μg/ml) at 4°C overnight, then washed 3 times and images were collected by fluorescence microscopy (Carl Zeiss, Germany).
Scanning Electron Microscope (SEM)
MDA-MB-231 cells (1×10 4 /ml) were cultured on PLLA-PDA, PLLA-PDA-IgG, and PLLA-PDA-CD40mAb scaffolds for 24h, and MC3T3-E1 cells (1×10 4 /ml) were cultured on PLLA-PDA, PLLA-PDA-IgG, and PLLA-PDA-CD40mAb scaffolds for 3 days. In briefs, scaffolds were harvested, washed with PBS and fixed with 4% 6 glutaraldehyde for 30 min at room temperature. Then the samples were dehydrated using graded ethanol series followed by three rinsing steps with distilled water. Dry specimens were sputter coated with gold and scanned by SEM.
Live/dead staining
Live/dead staining assay were performed using Live/Dead viability/cytotoxicity kit (Molecular Probes, USA). Briefly, MDA-MB-231 cells (1×10 4 /ml) were cultured on scaffolds for 24h and MC3T3-E1 cells (1×10 4 /ml) were cultured on scaffolds for 3d. 
In vitro cytotoxicity assay
The proliferation of MDA-MB-231 and MC3T3-E1 cells were measured by Cell Counting Kit-8 (CCK-8, Dojindo, Japan). Briefly, PLLA-PDA, PLLA-PDA-IgG， PLLA-PDA-CD40mAb were incubated in cell medium and the released buffer were collected at 12, 24, 48h. The cells (1×10 4 /ml) were subsequently incubated with those extracted buffer at 37 °C with 5% CO 2 on the 96-well plates (200μl/well). After incubation, the cell medium was removed and replaced with 100μl culture medium and 10μl CCK-8 reagent for another 2h for color development. The Optical density (OD) value was collected by the microplate reader (BioTek, USA) at 450 nm.
Identification of cell apoptosis
Cellular apoptosis of MDA-MB-231 cells were measured by Annexin V Apoptosis Detection Kit FITC (eBioscience, USA). Briefly, MDA-MB-231 cells were cultured in the released buffer of the scaffolds (24h released, final concentration, 1 μg/ml) for 24 h, cells were collected, and then resuspended. Subsequently, 5 μl Annexin V-FITC was added to 195 μl cell suspension and incubated for 10 min at room temperature in the dark. Then, cells were washed and resuspended in 200 μl Binding buffer with 5μl propidium iodide (1 μg/ml).
Last, the fluorescent signal was quantified with a Guava Easycyte HT system (Merk Millipore, Germany) and data was analyzed by Flowjo 7.6.1 software (TreeStar, USA).
qRT-PCR for gene expression
To assess the apoptosis-related gene expression, MDA-MB-231 cells (5×10 4 per ml) were seeded in the released buffer of the different grafted fibrous scaffolds (24 h released, final concentration, 1 μg/ml) for 1d. The total RNA was extracted using the TRIzolkit (Invitrogen, USA) according to the manufacturer's instructions, and the RNA concentration was determined by NanoDrop (Thermo Scientific, USA).
Reverse-transcribed into complementary DNA (cDNA) with the M-MLV reverse transcriptase kit (TaKaRa, Japan). By using a Brilliant SYBR Green QPCR Master Mix (TakaRa, Japan), the cDNA templates were subjected to qRT-PCR to semiquantify the gene expression. The primers (Table S1 ) were all obtained from Sangon (Shanghai, China). The relative gene expression data was analyzed using the 2 -△△Ct method. All gene expression values were normalized to the GAPDH level.
Induction of DC maturation
Under the approval of the Ethics Committee of the First Affiliated Hospital of Soochow University, periphere blood was collected after healthy donors gave written informed consent. Periphere blood mononuclear cells (PBMCs) were resuspended in RPMI1640 at cell density of 3×10 6 /ml and seeded in 24-well culture plate (0.5 ml/each), then incubated at 37 °C for 2h in a humidified incubator at 37°C with 5% CO 2 . Then the suspended cell were removed, and the adhesive cells from PBMC were replace with cell culture medium containing GM-CSF (100 ng/ml) and IL-4 (20 ng/ml), purified CD40mAb (1 μg/ml) or the released buffer (24 h, final concentration, 1 μg/ml) of the different grafted fibrous scaffolds, respectively. Cells were incubated in a humidified incubator at 37 °C with 5% CO 2 , the culture medium was changed each 3d. At d7, TNF-α (10 ng/ml) was added to the plates and cells were incubated for another 3d. The antibodies specific to human CD11c-APC, HLA-DR-PE (eBioscience, USA) were applied to stain the cells. 2 Cell phenotype was analyzed by FCA.
In vivo tumor therapy
The experiments were performed in accordance with the Guide for the Care and 
Statistical Analysis
One way ANOVA with the Tukey's post-hoc test were used to discern the statistical difference between groups. Data were presented as mean ± standard deviation (SD). 
